{"id":9444,"date":"2025-06-02T10:13:52","date_gmt":"2025-06-02T05:13:52","guid":{"rendered":"https:\/\/ksestocks.com\/blog\/?p=9444"},"modified":"2025-06-02T10:14:15","modified_gmt":"2025-06-02T05:14:15","slug":"adamjee-lifes-investment-portfolio-is-delivering-but-for-how-long","status":"publish","type":"post","link":"https:\/\/ksestocks.com\/blog\/adamjee-lifes-investment-portfolio-is-delivering-but-for-how-long\/","title":{"rendered":"Adamjee Life\u2019s investment portfolio is delivering, but for how long?"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Key takeaways<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ALIFE\u2019s profits surged 71% YoY in CY24 to <strong>PKR 1.6 billion (EPS: PKR 6.22)<\/strong>.<\/li>\n\n\n\n<li><strong>Gross premiums jumped 33%<\/strong> YoY, reaching <strong>PKR 31 billion<\/strong>\u2014driven mainly by Bancassurance.<\/li>\n\n\n\n<li><strong>Investment income soared 48%<\/strong> YoY to <strong>PKR 26.8 billion<\/strong>.<\/li>\n\n\n\n<li>Strategic shift away from single-premium products towards regular premiums is underway.<\/li>\n\n\n\n<li>Assets grew to <strong>PKR 116 billion<\/strong>, with <strong>PKR 106 billion<\/strong> in investments.<\/li>\n\n\n\n<li>Company faces IFRS-17 compliance challenges heading into 2026.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Profits climb, driven by core and investment gains<\/h2>\n\n\n\n<p><strong>Adamjee Life Assurance Company Ltd. (<a href=\"https:\/\/ksestocks.com\/blog\/tag\/alife\/\" target=\"_blank\" rel=\"noopener\" title=\"ALIFE\">ALIFE<\/a>)<\/strong> posted an impressive <strong>71% YoY growth in profits<\/strong> in CY24, with net income rising to <strong>PKR 1.6 billion<\/strong> from <strong>PKR 0.9 billion<\/strong> in CY23. EPS rose to <strong>PKR 6.22<\/strong>, underlining improved operational performance and healthy investment returns.<\/p>\n\n\n\n<p>The growth was supported by a <strong>33% increase in gross premium income<\/strong>, which rose to <strong>PKR 31 billion<\/strong>. The bulk of this revenue came from Bancassurance, which remains ALIFE\u2019s primary business vertical through key partnerships with MCB Bank and HMB Bank.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diversifying revenue streams<\/h2>\n\n\n\n<p>While Bancassurance remains dominant, ALIFE is also scaling its Direct Distribution, Insurtech &amp; Micro Insurance, and Group Life segments. Market share stands at:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>15.3%<\/strong> in Bancassurance<\/li>\n\n\n\n<li><strong>10%<\/strong> in Direct Distribution<\/li>\n\n\n\n<li><strong>7%<\/strong> in Group Life<\/li>\n<\/ul>\n\n\n\n<p>To reduce over-reliance on single-premium products, management aims to cut single premium income from <strong>PKR 15 billion in CY24 to PKR 10 billion in CY25<\/strong>, and instead grow <strong>regular premium products by 22% YoY<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Investment portfolio powers earnings surge<\/h2>\n\n\n\n<p>Investment income jumped by <strong>48% YoY<\/strong>, reaching <strong>PKR 26.8 billion<\/strong>, providing strong support to the bottom line.<\/p>\n\n\n\n<p>The portfolio, now valued at <strong>PKR 106 billion<\/strong>, is well-diversified:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>PKR 43 billion<\/strong> in PIBs and Ijara Sukuks<\/li>\n\n\n\n<li><strong>PKR 37 billion<\/strong> in T-Bills<\/li>\n\n\n\n<li><strong>PKR 15 billion<\/strong> in equities<\/li>\n\n\n\n<li><strong>PKR 7.4 billion<\/strong> in mutual funds<\/li>\n\n\n\n<li><strong>PKR 3.5 billion<\/strong> in TFCs<\/li>\n<\/ul>\n\n\n\n<p>ALIFE\u2019s investment strategy offers resilience against market volatility and supports sustainable growth.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Margins and challenges<\/h2>\n\n\n\n<p>Despite strong topline and investment income growth, underwriting margins slightly contracted. The <strong>net claims ratio stood at 80.4%<\/strong>, with <strong>commission expenses at 4.7%<\/strong> of net premiums. ALIFE\u2019s <strong>underwriting margin dropped to 10.0%<\/strong>, and is expected to edge lower to <strong>9.7%<\/strong> in CY25 due to falling interest rates.<\/p>\n\n\n\n<p>Another pressing issue: <strong>IFRS-17 implementation<\/strong>. The company anticipates challenges in meeting the Jan 2026 deadline due to technical resource shortages.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Balance sheet highlights<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Total assets<\/strong>: PKR 116 billion<\/li>\n\n\n\n<li><strong>Total liabilities<\/strong>: PKR 111 billion<\/li>\n\n\n\n<li><strong>Fixed assets<\/strong> surged nearly 3x due to IFRS-16 lease capitalization<\/li>\n\n\n\n<li><strong>Lease liabilities<\/strong> increased to PKR 661 million from PKR 103 million<\/li>\n<\/ul>\n\n\n\n<p>Despite growing obligations, ALIFE remains financially sound with adequate reserves and a forward-looking investment strategy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">A solid year with smart repositioning<\/h2>\n\n\n\n<p>Adamjee Life\u2019s CY24 performance reflects a company maturing into a more diversified and efficient life insurer. By reducing reliance on single-premium products and expanding its footprint across distribution channels, ALIFE is aiming for long-term stability.<\/p>\n\n\n\n<p>With strong investment income, improved premium flows, and a strategic asset allocation, the outlook remains promising. However, success will hinge on effective execution of IFRS-17 and navigating margin pressures from interest rate cuts.<\/p>\n\n\n\n<p>For investors seeking exposure to Pakistan\u2019s insurance sector, ALIFE\u2019s performance offers a compelling case.<\/p>\n\n\n\n<p><strong>Source: AKD Securities Ltd <\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adamjee Life Assurance Company Ltd. (ALIFE) posted an impressive 71% YoY growth in profits in CY24, with net income rising to PKR 1.6 billion from PKR 0.9 billion in CY23. EPS rose to PKR 6.22, underlining improved operational performance and healthy investment returns.<\/p>\n","protected":false},"author":9252,"featured_media":6432,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[154,155],"tags":[390],"class_list":["post-9444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-fundamental-analysis","tag-alife"],"featured_image_src":{"landsacpe":["https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2024\/11\/ALIFE-STOCK-PSX-1140x445.png",1140,445,true],"list":["https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2024\/11\/ALIFE-STOCK-PSX-463x348.png",463,348,true],"medium":["https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2024\/11\/ALIFE-STOCK-PSX-300x188.png",300,188,true],"full":["https:\/\/ksestocks.com\/blog\/wp-content\/uploads\/2024\/11\/ALIFE-STOCK-PSX.png",1920,1200,false]},"_links":{"self":[{"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/posts\/9444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/users\/9252"}],"replies":[{"embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/comments?post=9444"}],"version-history":[{"count":3,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/posts\/9444\/revisions"}],"predecessor-version":[{"id":9470,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/posts\/9444\/revisions\/9470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/media\/6432"}],"wp:attachment":[{"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/media?parent=9444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/categories?post=9444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ksestocks.com\/blog\/wp-json\/wp\/v2\/tags?post=9444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}